Elevar Therapeutics

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients.

[Elevar Therapeutics @ElevarTx]

This National Cancer Survivors Day, Elevar Therapeutics proudly stands with the millions of survivors, caregivers, and families who inspire our daily mission.

#NationalCancerSurvivorsDay #ElevarTx #ElevarTherapeutics #ElevatingOutcomes

[Elevar Therapeutics @ElevarTx]

The Elevar Therapeutics team wrapped up an energizing and highly productive week at the 2026 ASCO Annual Meeting in Chicago. It was incredible to connect with clinicians, researchers, and patient advocates to discuss our ongoing mission to elevate treatment options for those facing limited or inadequate therapeutic alternatives.

Key Highlights from #ASCO26
- Updates: We were thrilled to share new clinical insights with abstract #TPS4251: A Phase 2, open-label, single-arm study of lirafugratinib in patients with previously treated, unresectable, locally advanced, or metastatic solid tumors (excluding cholangiocarcinoma) with FGFR2 fusion or rearrangement.
- Meaningful Collaboration: The engagement at Booth #26027 at McCormick Place was inspiring. We had excellent conversations exploring how strategic partnerships can bridge the gap between early-stage innovation and global access to patient care.
- Advancing the Pipeline: The team walked away with fresh perspectives from across the oncology landscape, fueling our drive to push scientific boundaries and address critical unmet needs in cancer care.

Thank you to everyone who stopped by to connect, share insights, and discuss the future of oncology. We leave Chicago more motivated than ever to transform these scientific advancements into life-changing realities for patients worldwide.

If you weren't able to catch us in person, feel free to visit https://t.co/8JPldAkHzD to learn more about our pipeline and clinical progress.

#ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

Pride is about celebrating authenticity and lifting every voice.

Elevar Therapeutics is proud to recognize Pride Month by highlighting the importance of diversity in scientific innovation. By fostering a truly inclusive and compassionate workplace culture, we ensure our team feels valued and empowered to improve outcomes for underserved patients worldwide.

#PrideMonth #ElevarTx #ElevarTherapeutics #ElevarCulture

[Elevar Therapeutics @ElevarTx]

Stop by booth #26027 and say hello to our amazing team!

#ASCO26 #ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

Did you know we are also on LinkedIn? Follow us to keep up with the latest news and updates.
#ElevarTx #ElevarTherapeutics #FollowUs

[Elevar Therapeutics @ElevarTx]

Today, Elevar Therapeutics pauses to remember and honor the service members who made the ultimate sacrifice for our freedom.

Their legacy of courage inspires our daily mission to improve and extend human life. We are forever grateful for their service.

#MemorialDay #ElevarTx #ElevarTherapeutics #ElevarCulture #Gratitude

[Elevar Therapeutics @ElevarTx]

Elevating awareness for #HepatitisTestingDay!

At Elevar Therapeutics, we are committed to transforming care for patients facing complex liver diseases. Today, we stand with the global health community to emphasize a critical message: Knowledge is power.

Chronic viral hepatitis often goes undetected for years, but early testing can lead to life-saving interventions and better long-term outcomes. By prioritizing screening, we can help reduce the burden of liver cancer and other complications that impact millions worldwide.

We are proud to support the researchers, clinicians, and advocates working tirelessly to bridge the gap between diagnosis and treatment. Together, we can strive for a future where hepatitis is no longer a silent threat.

Have you checked your status? Talk to your healthcare provider today.

#ElevarTx #ElevarTherapeutics #HepatitisAwareness #LiverHealth #EarlyDetection

[Elevar Therapeutics @ElevarTx]

May is Mental Health Awareness Month, a crucial time to acknowledge that well-being is not just about physical health, it's about mental wellness, too.

At Elevar Therapeutics, our mission is rooted in elevating treatment experiences for patients and caregivers who face difficult, under-treated health conditions. We know that caring for others begins with caring for ourselves and our teams.

Let’s continue to build a supportive community where everyone feels valued and understood.

#MentalHealthAwarenessMonth #ElevarCares #MentalHealthMatters #ElevarCulture #ElevatingOutcomes #ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

Elevar Therapeutics is heading to ASCO 2026!

We are excited to join the global oncology community in Chicago to share our latest clinical progress and engage with partners committed to transforming cancer care.

Our team is focused on advancing innovative therapies for patients with limited options, and we look forward to a week of groundbreaking science and meaningful collaboration.

Where to find us: Booth #26027

See you in Chicago!

#ASCO26 #ElevarTx #ElevarTherapeutics #CancerResearch

[Elevar Therapeutics @ElevarTx]

This National Women's Health Week, Elevar Therapeutics is focused on the future.

Our mission is to elevate treatment experiences for patients with limited options, with a special focus on developing innovative oncology treatments.

Together with our partners, we are committed to transforming outcomes and shaping a healthier future.

#NWHW #ElevarTx #ElevarTherapeutics #WomensHealth #OncologyResearch #Innovation

[Elevar Therapeutics @ElevarTx]

Today, we’re celebrating all the incredible mothers on our team and beyond.

At Elevar Therapeutics, we know that balancing professional dedication with the strength and grace of motherhood is no small feat. To all the moms, moms-to-be, and mother figures who inspire us, both at home and in our mission to elevate patient care, we thank you.

We are grateful for your passion, resilience, and the nurturing spirit you bring to everything you do.

Happy Mother’s Day!

#MothersDay #ElevarCares #WomenInScience #ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

Today, on #NationalNursesDay, Elevar celebrates the incredible dedication of nurses working to advance treatment for those affected by #HCC and other serious diseases. Your expertise, compassion, and commitment truly change lives.
#OncologyNursing #PatientCare #ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

Heading to the Annual CCF Conference? Connect with Elevar!
We are thrilled to be part of the Cholangiocarcinoma Foundation's annual conference, engaging with clinicians, researchers, and caregivers dedicated to transforming biliary tract cancer care.
Missed our latest data? Come by to view our Encore Poster presentation to learn more about Elevar’s ongoing commitment to elevating treatment outcomes for patients.
We look forward to connecting and collaborating to make a difference.
#CCF26 #ElevarTx #ElevarTherapeutics #ElevatingOutcomes #Cholangiocarcinoma #CancerResearch

[Elevar Therapeutics @ElevarTx]

We are pleased to announce that an abstract focusing on our investigational, highly selective FGFR2 inhibitor, lirafugratinib, will be presented at the 2026 ASCO Annual Meeting.

As we advance our mission to bring life-changing medicines to patients with limited options, this abstract highlights our commitment to addressing the unmet needs of patients.

Abstract #: TPS4251

Study: A Phase 2, open-label, single-arm study of lirafugratinib in patients with previously treated, unresectable, locally advanced, or metastatic solid tumors (excluding cholangiocarcinoma) with FGFR2 fusion or rearrangement.

Focus: The ELE-4008-202, phase 2, open-label, single-arm study (NCT07359820) is designed to further evaluate the efficacy and safety of lirafugratinib 70 mg in patients with FGFR2 f/r, previously treated, unresectable, locally advanced or metastatic, non-CCA solid tumors who have not received prior FGFR inhibitor therapy (Richard Kim, MD, Moffit Cancer Center).

#ElevarTx #ElevarTherapeutics #Lirafugratinib #FGFR2 #ASCO26

[Elevar Therapeutics @ElevarTx]

Happy Earth Day from Elevar Therapeutics!

By embracing remote and hybrid work, we are reducing our carbon footprint, lessening daily commute emissions, and creating a sustainable future. Together, we’re committed to protecting our planet while innovating for patients. #EarthDay #RemoteWork #ElevarTx #ElevarTherapeutics

[Elevar Therapeutics @ElevarTx]

We are excited to announce that Elevar Therapeutics will be at the AACR Annual Meeting in San Diego!

Join us to learn more about our latest research during a poster presentation by Grace Lee, PhD. Kevin N. Heller, MD, will also be in attendance to connect with colleagues and discuss our ongoing commitment to advancing cancer care.

We look forward to sharing our findings and engaging with the global cancer research community. See you in San Diego!

#AACR26 #ElevarTx #ElevarTherapeutics #Oncology #CancerResearch

[Elevar Therapeutics @ElevarTx]

April is #AlcoholAwarenessMonth
Did you know that alcohol is responsible for about 1 in 3 cases of liver cancer in the U.S.? Excessive consumption can lead to cirrhosis, the biggest risk factor for Hepatocellular Carcinoma (HCC).
At Elevar Therapeutics, we are relentless in our pursuit of "Elevating Outcomes" for patients with our commitment to oncology research.
This month, let’s prioritize liver health:
- Limit alcohol consumption
- Stay informed about liver cancer risk factors
- Support the development of next-generation therapies
#ElevarTx #ElevarTherapeutics #LiverCancerAwareness #uHCC

[Elevar Therapeutics @ElevarTx]

We are thrilled to be in Boston at the Simches Research Center today for the 2026 Boston Cholangiocarcinoma Regional Symposium!

At Elevar Therapeutics, our mission is to elevate treatment outcomes for patients with limited therapeutic options. Today’s symposium is a vital platform for connecting with the patients, caregivers, and medical experts who drive our work forward in the fight against cholangiocarcinoma (CCA).

This event comes at an exciting time for our team. We recently reached a major milestone with the FDA’s filing acceptance and Priority Review of our New Drug Application (NDA) for lirafugratinib, an investigational therapy for patients with FGFR2-driven CCA.

If you are attending, come find our team! We look forward to a day of meaningful dialogue and progress.

#ElevarTx #ElevarTherapeutics #CCA #CureCCA

[Elevar Therapeutics @ElevarTx]

At Elevar, we believe that our best work happens when our team feels their best.

That’s why we’re celebrating Elevar Day. It’s our way of saying thank you to the incredible people who make this company what it is.

Today, the entire team is taking a well-deserved day off to unplug, recharge, and enjoy life outside of work. Whether it’s spending time with family, getting outdoors, or simply catching up on rest, this day is all about giving our team the space to truly thrive.

We know that taking time to reset isn't just a perk, it’s essential for long-term success and creativity.

#ElevarDay #ElevarCulture #ElevarTx #ElevarTherapeutics